openPR Logo
Press release

Circulating Tumor Cells Prognostic Technologies Market Opportunity Analysis and Industry Forecast upto 2020

10-04-2017 11:33 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Circulating Tumor Cells Prognostic Technologies Market

A new market research study, published by Transparency Market Research is titled “Circulating Tumor Cells (CTCs) Prognostic Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020.” This study provides a detailed analysis of the market, focusing on the current trends, major growth drivers, and barriers. The product segmentation, major geographical segments, and competitive landscape of the CTCs prognostic technologies market have also been mentioned in the research report. According to the study, in 2013, the global circulating tumor cells prognostic technologies market for was worth US$0.43 bn. The market is projected to register an impressive 26.30% CAGR between 2014 and 2020, reaching a value of US$2.16 bn by the end of 2020.

Circulating tumor cells refer to specialized rare cells that are separated from the primary tumors, which further spread in the vasculature system of the human body. The dissemination of these cells further causes metastasis. CTCs act as a seed for the development of metastatic tumors in the vital distant organs; these tumors are considered as a major cause for cancer-related deaths. Technological developments in this field are one of the major factors contributing substantially towards the growth of the market.

View and Download TOC of Circulating Tumor Cells (CTCs) Prognostic Technologies Market Research Report@ https://www.transparencymarketresearch.com/report-toc/2497

Furthermore, the growing prevalence rate of cancer, increasing evaluation of therapeutic monitoring, and high cost-benefit ratio are some of the other factors propelling the global CTCs prognostic technologies market. However, the lack of sensitivity and specificity and high costing associated with CTCs detection are projected to curtail the growth of the market in the coming years.

By application, the global CTCs prognostic technologies market has been classified into prostate cancer, colorectal cancer, breast cancer, and others. The others segment has been sub-classified into ovarian, pancreatic, and lung cancer. Among these, the prostate cancer segment is anticipated to exhibit a progressive 25.20% CAGR between 2014 and 2020. On the other hand, the breast cancer segment is estimated to register an impressive 27.10% CAGR between 2014 and 2020.

Request and Download Sample Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2497

By geography, the global CTCs prognostic technologies market has been broadly divided into Europe, Asia Pacific, North America, and Rest of the World. At present, North America accounts for the largest share in the global CTCs prognostic technologies market and is anticipated to remain in this position in the next few years. The rapid growth of this region can be attributed to the growing adoption rate for advanced prognostic technologies and rising incidence of cancer across the globe. Nevertheless, the high development cost and low commercial viability of these technologies are some of the key factors leading to sluggish growth of the market. Furthermore, the Asia Pacific market for CTCs prognostic technologies is projected to witness substantial growth throughout the forecast period, owing to the increasing research and development activities in this region.

The leading players operating in the global circulating tumor cells prognostic technologies market include Vitatex, Inc., Rarecells USA, Inc., Fluxion Biosciences, Inc., AdnaGen GmbH, Advanced Cell Diagnostics, Inc., Epic Sciences, Inc., Celula, Inc., AVIVA Biosciences Corporation, Veridex, LLC, and Silicon Biosystems, S.p.A. To provide a clear understanding of the market, the research study has mentioned the company profiles, contact information, financial status, business strategies, SWOT analysis, and recent news and developments, if any.

Buy Full Circulating Tumor Cells (CTCs) Prognostic Technologies Market Report@ https://www.transparencymarketresearch.com/checkout.php?rep_id=2497<ype=S

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Circulating Tumor Cells Prognostic Technologies Market Opportunity Analysis and Industry Forecast upto 2020 here

News-ID: 754542 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for CTCs

Circulating Tumor Cells (CTCs) Market Analysis by Leading Manufacturers (Gilupi, …
HTF MI recently introduced study “Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, Status and Forecast 2025” with in-depth focused approach on qualitative research, describing product Scope and elaborating industry insights and outlook to 2022. The market Study is putting a lot of emphasis on macro-economic issues, influencing factors and key market trends and drivers gearing up and are changing the dynamics of Global Circulating Tumor
Jan 24, 2018: Circulating Tumor Cells (CTCs) Detectors Market Share 2023 Qiagen, …
Circulating Tumor Cells (CTCs) Detectors Market Research 2018 A market study ” Global Circulating Tumor Cells (CTCs) Detectors Market ” examines the performance of the Circulating Tumor Cells (CTCs) Detectors market 2018. It encloses an in-depth Research of the Circulating Tumor Cells (CTCs) Detectors market state and the competitive landscape globally. This report analyzes the potential of Circulating Tumor Cells (CTCs) Detectors market in the present and the future prospects from
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)Market Research, Dema …
HTF MI published a new industry research that focuses on Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market and delivers in-depth market analysis and future prospects of Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market. The study covers significant data which makes the research document a handy resource for managers, analysts, industry experts and other key people get ready-to-access and self-analyzed study along with graphs
Global Circulating Tumor Cells (CTCs) Detectors Industry 2017 Market Research Re …
Global Circulating Tumor Cells (CTCs) Detectors Industry 2021 Market Research Report analyzed the current state in the definitions, classifications, applications and industry chain structure. The report also focuses on the development trends as well as history, competitive landscape analysis, and key regions etc in the international markets. Global Circulating Tumor Cells (CTCs) Detectors Industry 2021 Market Research Report is a professionally prepared report comprising of in-depth information as well as knowledge
Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report …
Latest market study on " Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report: 2017 " available with Single User Global USD 2900 at OrbisResearch.com The Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market report covers the present scenario and the growth prospects of the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market for 2017-2021 The report covers the market landscape and
Circulating Tumor Cells (CTCs) Detector Global Industry: Trends and Forecast 201 …
Researchmoz added Most up-to-date research on "Circulating Tumor Cells (CTCs) Detector Global Industry: Trends and Forecast 2018" to its huge collection of research reports. 2016 Global Circulating Tumor Cells (CTCs) Detector Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Circulating Tumor Cells (CTCs) Detector industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States,